BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 18467582)

  • 1. Toward an AIDS vaccine.
    Walker BD; Burton DR
    Science; 2008 May; 320(5877):760-4. PubMed ID: 18467582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Theory for prophylactic AIDS vaccine development].
    Nomura T; Matano T
    Uirusu; 2009 Dec; 59(2):267-75. PubMed ID: 20218335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
    Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
    Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of prophylactic vaccines against HIV-1.
    Schiffner T; Sattentau QJ; Dorrell L
    Retrovirology; 2013 Jul; 10():72. PubMed ID: 23866844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection from HIV infection or AIDS?
    Miedema F; Meyaard L; Klein MR
    Science; 1993 Nov; 262(5136):1074-6. PubMed ID: 8235627
    [No Abstract]   [Full Text] [Related]  

  • 7. 25 years of HIV research! ... and what about a vaccine?
    Appay V
    Eur J Immunol; 2009 Aug; 39(8):1999-2003. PubMed ID: 19672891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of prophylactic AIDS vaccines: the current state of affairs.
    Hanke T
    Curr Opin Mol Ther; 2003 Feb; 5(1):25-32. PubMed ID: 12669467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunology and the elusive AIDS vaccine.
    Virgin HW; Walker BD
    Nature; 2010 Mar; 464(7286):224-31. PubMed ID: 20220841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HIV vaccine: how far along are we?].
    Reiss EIMM; van Gils MJ; Sanders RW; de Bree GJ
    Ned Tijdschr Geneeskd; 2020 Sep; 164():. PubMed ID: 33030332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress toward an HIV vaccine.
    Letvin NL
    Annu Rev Med; 2005; 56():213-23. PubMed ID: 15660510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIDS vaccines: back to 'plan A'.
    Check E
    Nature; 2003 Jun; 423(6943):912-4. PubMed ID: 12827164
    [No Abstract]   [Full Text] [Related]  

  • 13. T lymphocyte responses in HIV-1 infection: implications for vaccine development.
    Brander C; Walker BD
    Curr Opin Immunol; 1999 Aug; 11(4):451-9. PubMed ID: 10448136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tat protein vaccination of cynomolgus macaques influences SHIV-89.6P cy243 epitope variability.
    Ridolfi B; Genovese D; Argentini C; Maggiorella MT; Sernicola L; Buttò S; Titti F; Borsetti A; Ensoli B
    Virus Genes; 2008 Feb; 36(1):105-15. PubMed ID: 18049888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV vaccines: prospects and challenges.
    Baltimore D; Heilman C
    Sci Am; 1998 Jul; 279(1):98-103. PubMed ID: 9648305
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trials of HIV vaccines.
    Graham BS
    Annu Rev Med; 2002; 53():207-21. PubMed ID: 11818471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.
    Barouch DH; Kunstman J; Kuroda MJ; Schmitz JE; Santra S; Peyerl FW; Krivulka GR; Beaudry K; Lifton MA; Gorgone DA; Montefiori DC; Lewis MG; Wolinsky SM; Letvin NL
    Nature; 2002 Jan; 415(6869):335-9. PubMed ID: 11797012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in the search for an HIV vaccine.
    Lemckert AA; Goudsmit J; Barouch DH
    Eur J Epidemiol; 2004; 19(6):513-6. PubMed ID: 15330122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants.
    Rose NF; Marx PA; Luckay A; Nixon DF; Moretto WJ; Donahoe SM; Montefiori D; Roberts A; Buonocore L; Rose JK
    Cell; 2001 Sep; 106(5):539-49. PubMed ID: 11551502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.
    Amara RR; Villinger F; Altman JD; Lydy SL; O'Neil SP; Staprans SI; Montefiori DC; Xu Y; Herndon JG; Wyatt LS; Candido MA; Kozyr NL; Earl PL; Smith JM; Ma HL; Grimm BD; Hulsey ML; Miller J; McClure HM; McNicholl JM; Moss B; Robinson HL
    Science; 2001 Apr; 292(5514):69-74. PubMed ID: 11393868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.